Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Recruiting
- Conditions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT06571396
- Locations
- 🇨🇳
Qilu hospital of Shandong university, Jinan, Shandong, China
Neoadjuvant Therapy in Cervical Cancer
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 48
- Registration Number
- NCT06558682
Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 900
- Registration Number
- NCT06552975
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Efficacy of Sacral Nerve Modulation on Urinary and Defecation Dysfunction After Spinal Cord Injury：A Prospective, Single-arm Study
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 41
- Registration Number
- NCT06553469
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Fluzoparib Neoadjuvant Therapy for Ovarian Cancer
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 48
- Registration Number
- NCT06541314
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Difficult Colonoscopy and Personality Traits
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 450
- Registration Number
- NCT06531226
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 43
- Registration Number
- NCT06500247
- Locations
- 🇨🇳
Qilu hospital, Jinan, Shandong, China
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 150
- Registration Number
- NCT06496360
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 30
- Registration Number
- NCT06454578
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-20
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 484
- Registration Number
- NCT06421220
- Locations
- 🇨🇳
Qilu hospital of Shandong University, Jinan, Shandong, China
© Copyright 2024. All Rights Reserved by MedPath